BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 1374058)

  • 1. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.
    Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ
    Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
    Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
    Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
    Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
    Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
    Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
    Ninomiya H; Kobayashi T; Abe T
    Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic analysis of affected peripheral erythroid for CD59 in paroxysmal nocturnal hemoglobinuria.
    Cui W; Lin Q; Zhang Z
    Chin Med J (Engl); 2002 Feb; 115(2):206-8. PubMed ID: 11940332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Fc gamma R-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor.
    Ninomiya H; Muraki Y; Shibuya K; Nagasawa T; Abe T
    Br J Haematol; 1993 Jul; 84(3):497-503. PubMed ID: 7692930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidylinositol-anchored antigens.
    Lund-Johansen F; Olweus J; Symington FW; Arli A; Thompson JS; Vilella R; Skubitz K; Horejsi V
    Eur J Immunol; 1993 Nov; 23(11):2782-91. PubMed ID: 8223854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria.
    Dworacki G; Sikora J; Mizera-Nyczak E; Trybus M; Mozer-Lisewska I; Czyz A; Zeromski J
    Folia Histochem Cytobiol; 2005; 43(2):117-20. PubMed ID: 16044949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
    Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
    Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic and phenotypic implications in paroxysmal nocturnal hemoglobinuria (PNH): a preliminary investigation.
    Pakdeesuwan K; Siripanyaphinyo U; Pramoonjago P; Pattanapanyasat K; Wilairat P; Kinoshita T; Wanachiwanawin W
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():58-63. PubMed ID: 9640601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
    Fujioka S; Yamada T
    Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
    Hillmen P; Hows JM; Luzzatto L
    Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of PI (phosphatidylinositol)-anchoring antigens in a patient of paroxysmal nocturnal hemoglobinuria (PNH) reveals deficiency of 1F5 antigen (CD59), a new complement-regulatory factor.
    Taguchi R; Funahashi Y; Ikezawa H; Nakashima I
    FEBS Lett; 1990 Feb; 261(1):142-6. PubMed ID: 1689670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.